litlas
Log inCreate account

Amit Bar‐Or

Active 1992–2025

Also published as
Amit Bar-Or
242
Papers
43,767
Citations
110
h-index
226
i10-index

Citations

Citations per year for Amit Bar‐Or1973: 3 citations1993: 1 citations1994: 5 citations1995: 6 citations1996: 6 citations1997: 5 citations1998: 2 citations1999: 3 citations2000: 3 citations2001: 9 citations2002: 18 citations2003: 16 citations2004: 35 citations2005: 65 citations2006: 91 citations2007: 88 citations2008: 159 citations2009: 202 citations2010: 231 citations2011: 264 citations2012: 272 citations2013: 339 citations2014: 370 citations2015: 469 citations2016: 389 citations2017: 457 citations2018: 534 citations2019: 1,705 citations2020: 2,024 citations2021: 2,246 citations2022: 1,871 citations2023: 1,289 citations2024: 2,055 citations2025: 1,124 citations2026: 22 citations1974–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,701 citing papers, 22.2% of this breakdownGermany: 1,346 citing papers, 8.1% of this breakdownChina: 1,278 citing papers, 7.7% of this breakdownUnited Kingdom: 1,150 citing papers, 6.9% of this breakdownItaly: 1,089 citing papers, 6.5% of this breakdownCanada: 935 citing papers, 5.6% of this breakdownSwitzerland: 615 citing papers, 3.7% of this breakdownFrance: 604 citing papers, 3.6% of this breakdownAustralia: 486 citing papers, 2.9% of this breakdownSpain: 465 citing papers, 2.8% of this breakdownNetherlands: 454 citing papers, 2.7% of this breakdownJapan: 331 citing papers, 2% of this breakdown
0%22.2%Other 25.3%

Institutions

Fields

  • Medicine56.8%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Immunology and Microbiology13.3%
  • Neuroscience12.8%
  • Agricultural and Biological Sciences0.3%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • Other1.7%

Topics

  • Multiple Sclerosis Research Studies13.1%
  • Neuroinflammation and Neurodegeneration Mechanisms5.9%
  • Peripheral Neuropathies and Disorders4.7%
  • T-cell and B-cell Immunology3.9%
  • Immunotherapy and Immune Responses2.9%
  • Immune Cell Function and Interaction2.8%
  • Other66.7%

Coauthors

All papers

Open in search
  1. Multiple sclerosis

    Authors: Massimo Filippi, Amit Bar‐Or, Fredrik Piehl, Paolo Preziosa, Alessandra Solari, Sandra Vukusic, Maria A. Rocca - Nature Reviews Disease Primers 2018 cited by 1,398

  2. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

    Authors: Stephen L. Hauser, Amit Bar‐Or, Gıancarlo Comı, Gavin Giovannoni, Hans‐Peter Hartung, Bernhard Hemmer, Fred Lublin, Xavier Montalbán, Kottil Rammohan, Krzysztof Selmaj, Anthony Traboulsee, Jerry S. Wolinsky, Douglas L. Arnold, Gaëlle Klingelschmitt, Donna Masterman, Paulo Fontoura, Shibeshih Belachew, Peter Chin, Nicole Mairon, Hideki Garren, Ludwig Kappos - New England Journal of Medicine 2016 cited by 1,961

  3. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Authors: Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold, Amit Bar‐Or, Giancarlo Comi, de Sèze, Gavin Giovannoni, Hans‐Peter Hartung, Bernhard Hemmer, Fred Lublin, Kottil Rammohan, Krzysztof Selmaj, Anthony Traboulsee, Annette Sauter, Donna Masterman, Paulo Fontoura, Shibeshih Belachew, Hideki Garren, Nicole Mairon, Peter Chin, Jerry S. Wolinsky - New England Journal of Medicine 2016 cited by 1,856

  4. Ofatumumab versus Teriflunomide in Multiple Sclerosis

    Authors: Stephen L. Hauser, Amit Bar‐Or, Jeffrey Cohen, Gıancarlo Comı, Jorge Correale, Patricia K. Coyle, Anne H. Cross, de Sèze, David Leppert, Xavier Montalbán, Krzysztof Selmaj, Heinz Wiendl, Cécile Kerloëguen, Roman Willi, Bingbing Li, Algirdas Kakarieka, Davorka Tomic, Alexandra Goodyear, Ratnakar Pingili, Dieter A. Häring, Krishnan Ramanathan, Martin Merschhemke, Ludwig Kappos - New England Journal of Medicine 2020 cited by 700

  5. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course

    Authors: Xiaoyuan Zhou, Ryan Baumann, Xiaohui Gao, Myra Mendoza, Sneha Singh, Ilana Katz Sand, Zongqi Xia, Laura M. Cox, Tanuja Chitnis, Hongsup Yoon, Laura Moles, Stacy J. Caillier, Adam Santaniello, Gail Ackermann, Adil Harroud, Robin Lincoln, Refujia Gomez, Antonio González Peña, Elise Digga, Daniel Hakim, Yoshiki Vázquez‐Baeza, Karthik Soman, Shannon Warto, Greg Humphrey, Mauricio Farez, Lisa Ann Gerdes, Jorge R. Oksenberg, Scott S. Zamvil, Siddharthan Chandran, Peter Connick, David Otaegui, Tamara Castillo‐Triviño, Stephen L. Hauser, Jeffrey M. Gelfand, Howard L. Weiner, Reinhard Hohlfeld, Hartmut Wekerle, Jennifer Graves, Amit Bar‐Or, Bruce Cree, Jorge Correale, Rob Knight, Sergio E. Baranzini - Cell 2022 cited by 319

  6. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    Authors: Ludwig Kappos, Amit Bar‐Or, Bruce Cree, Robert J. Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L. Arnold, Sophie Arnould, Tatiana Scherz, Christian Wolf, Erik Wallström, Frank Dahlke, Anat Achiron, Lutz Achtnichts, Kadriye Ağan, Gülşen Akman‐Demir, Alison Allen, Jack P. Antel, Alfredo Rodríguez Antigüedad, Michelle Apperson, Angela Applebee, Guillermo Izquierdo Ayuso, Masayuki Baba, Ovidiu Băjenaru, Rodica Balasa, Belgin Petek Balcı, Michael Barnett, Ann Bass, V. Becker, Mihaela Bejinariu, Florian Then Bergh, Arnfin Bergmann, Evanthia Bernitsas, Achim Berthele, Virender Bhan, Felix Bischof, Randall J. Bjork, Gregg Blevins, Matthias Boehringer, Thomas Boerner, Robert Bonek, James D. Bowen, Allen C. Bowling, Alexey Boyко, Cavit Boz, Vera Bracknies, Stefan Braune, Vincenzo Brescia Morra, Bruno Brochet, Waldemar Brola, Paul Brownstone, M Brozman, Donald Brunet, Ioan Buraga, Margaret Burnett, Mathias Buttmann, Helmut Butzkueven, Jonathan Cahill, Jonathan Calkwood, William Camu, Mark Cascione, G. Castelnovo, Diego Centonze, João Cerqueira, Andrew Chan, Andrea Cimprichová, Stanley Cohan, Giancarlo Comi, Jill Ker Conway, Joanna A. Cooper, John R. Corboy, Jorge Correale, Brian Costell, David A. Cottrell, Patricia K. Coyle, Matthew Craner, Liying Cui, Luı́s Cunha, Anna Członkowska, Ana Silva, Joao de, de Sèze, Marc Debouverie, Jan Debruyne, D. Decoo, G. Defer, Tobias Derfuß, Norma Deri, Bhupesh Dihenia, Péter Diószeghy, Vladimír Donáth, Bénédicte Dubois, Martin Duddy, Pierre Duquette, Gilles Edan, Hüsnü Efendi, Stanton B. Elias, Peter Emrich, Bonaventura Casanova Estruch and 228 more - The Lancet 2018 cited by 925

  7. B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

    Authors: Stephen L. Hauser, Emmanuelle Waubant, Douglas L. Arnold, Timothy R. Vollmer, Jack P. Antel, Robert J. Fox, Amit Bar‐Or, Michael Panzara, Neena Sarkar, Sunil Agarwal, Annette Langer‐Gould, Craig H. Smith - New England Journal of Medicine 2008 cited by 2,399

  8. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

    Authors: Ralf Gold, Ludwig Kappos, Douglas L. Arnold, Amit Bar‐Or, Gavin Giovannoni, Krzysztof Selmaj, Carlo Tornatore, Marianne T. Sweetser, Minhua Yang, Sarah Sheikh, Katherine Dawson - New England Journal of Medicine 2012 cited by 1,703

  9. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

    Authors: Ping Shen, Toralf Roch, Vicky Lampropoulou, Richard A. O’Connor, Ulrik Stervbo, Ellen Hilgenberg, Stefanie Ries, Van Duc Dang, Yarúa Jaimes, Capucine Daridon, Rui Li, Luc Jouneau, Pierre Boudinot, Siska Wilantri, Imme Sakwa, Yusei Miyazaki, Melanie D. Leech, Rhoanne C. McPherson, Stefan Wirtz, Markus F. Neurath, Kai Hoehlig, Edgar Meinl, Andreas Grützkau, Joachim R. Grün, Katharina Horn, Anja A. Kühl, Thomas Dörner, Amit Bar‐Or, Stefan H. E. Kaufmann, Stephen M. Anderton, Simon Fillatreau - Nature 2014 cited by 1,032

  10. Role of B Cells in Multiple Sclerosis and Related Disorders

    Authors: Gıancarlo Comı, Amit Bar‐Or, Hans Lassmann, Antonio Uccelli, Hans‐Peter Hartung, Xavier Montalbán, Per Solberg Sørensen, Reinhard Hohlfeld, Stephen L. Hauser - Annals of Neurology 2020 cited by 278

  11. Bruton tyrosine kinase inhibitors for multiple sclerosis

    Authors: Julia Krämer, Amit Bar‐Or, Timothy J. Turner, Heinz Wiendl - Nature Reviews Neurology 2023 cited by 184

  12. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

    Authors: Daniel S. Reich, Douglas L. Arnold, Patrick Vermersch, Amit Bar‐Or, Robert J. Fox, André Palma da Cunha Matta, Timothy J. Turner, Erik Wallström, Xinyan Zhang, Miroslav Mareš, Ф. А. Хабиров, Anthony Traboulsee, François Grand’Maison, François Jacques, Anthony Traboulsee, Michaela Týblová, Eva Meluzínová, Radek Ampapa, Martin Vališ, Pavel Hradilke, Miroslav Mareš, Pavel Štourač, Katrin Gross‐Paju, David Laplaud, Guillaume Mathey, Bernard M.J. Uitdehaag, Evgeny Evdoshenkoo, Е. В. Попова, Maria Zakharova, N. А. Totolyan, И. В. Литвиненко, Ф. А. Хабиров, С А Сиверцева, Viera Hančinová, Ema Kantorová, María Luisa Martínez Ginés, Xavier Montalbán, Sara Eichau Maduano, José Meca-Lallana, Lluís Ramió‐Torrentà, Tetyanna Nehrych, V.M. Pashkovskyy, Sergii Moskovko, O. I. Kalbus, Marta Khavunka, Volodymyr Pryshchepa, Alla Goloborodko, Daniel Wynn, William Honeycutt, Sibyl Wray, Brian Steingo, Christopher LaGanke, DeRen Huang, John M. Hemphill, Lawrence Goldstick, Derrick Robertson - The Lancet Neurology 2021 cited by 192

  13. Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype

    Authors: Konrad Gabrusiewicz, Benjamin A.T. Rodriguez, Jun Wei, Yuuri Hashimoto, Luke M. Healy, Sourindra N. Maiti, Ginu Thomas, Shouhao Zhou, Qianghu Wang, Ahmed Elakkad, Brandon Liebelt, Nasser K. Yaghi, Ravesanker Ezhilarasan, Neal Huang, Jeffrey S. Weinberg, Sujit S. Prabhu, Ganesh Rao, Raymond Sawaya, Lauren A. Langford, Janet M. Bruner, Gregory N. Fuller, Amit Bar‐Or, Wei Li, Rivka R. Colen, Michael A. Curran, Krishna Bhat, Jack P. Antel, Laurence J.N. Cooper, Erik P. Sulman, Amy B. Heimberger - JCI Insight 2016 cited by 454

  14. Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10

    Authors: Olga L. Rojas, Anne‐Katrin Pröbstel, Elisa A. Porfilio, A. Wang, Marc Charabati, Tian Sun, Dennis S. W. Lee, Georgina Galicia, Valeria Ramaglia, Lesley A. Ward, Leslie Y. T. Leung, Ghazal Najafi, Khashayar Khaleghi, Beatriz Garcillán, Angela Li, Rickvinder Besla, Ikbel Naouar, Eric Cao, Pailin Chiaranunt, Kyle Burrows, Hannah G Robinson, Jessica R. Allanach, Jennifer Yam, Helen Luck, Daniel Campbell, David Allman, David G. Brooks, Michio Tomura, Ryan Baumann, Scott S. Zamvil, Amit Bar‐Or, Marc S. Horwitz, Daniel A. Winer, Arthur Mortha, Fabienne Mackay, Alexandre Prat, Lisa C. Osborne, Clinton S. Robbins, Sergio E. Baranzini, Jennifer L. Gommerman - Cell 2019 cited by 388

  15. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

    Authors: Sokratis A. Apostolidis, Mihir Kakara, Mark M. Painter, Rishi R. Goel, Divij Mathew, Kerry Lenzi, Ayman Rezk, Kristina R. Patterson, Diego A. Espinoza, Jessy C. Kadri, Daniel Markowitz, Clyde Markowitz, Ina Mexhitaj, Dina Jacobs, Allison Babb, Michael R. Betts, Eline T. Luning Prak, Daniela Weiskopf, Alba Grifoni, Kendall A. Lundgreen, Sigrid Gouma, Alessandro Sette, Paul Bates, Scott E. Hensley, Allison R. Greenplate, E. John Wherry, Rui Li, Amit Bar‐Or - Nature Medicine 2021 cited by 543

  16. Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances

    Authors: Amit Bar‐Or, Rui Li - The Lancet Neurology 2021 cited by 231

  17. Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy

    Authors: Rui Li, Ayman Rezk, Yusei Miyazaki, Ellen Hilgenberg, Hanane Touil, Ping Shen, Craig S. Moore, Laure Michel, Faisal Althekair, Sathy Rajasekharan, Jennifer L. Gommerman, Alexandre Prat, Simon Fillatreau, Amit Bar‐Or, on behalf of the Canadian B cells in MS Team - Science Translational Medicine 2015 cited by 445

  18. Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials

    Authors: Amit Bar‐Or, Gian‐Andrea Thanei, Christopher Harp, Corrado Bernasconi, Ulrike Bonati, Anne H. Cross, Saloumeh K Fischer, Laura Gaetano, Stephen L. Hauser, Robert L. Hendricks, Ludwig Kappos, Jens Kühle, David Leppert, Fabian Model, Annette Sauter, Harold Koendgen, Xiaoming Jia, Ann Herman - EBioMedicine 2023 cited by 88

  19. Reassessing B cell contributions in multiple sclerosis

    Authors: Rui Li, Kristina R. Patterson, Amit Bar‐Or - Nature Immunology 2018 cited by 407

  20. B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies

    Authors: Maria Teresa Cencioni, Miriam Mattoscio, Roberta Magliozzi, Amit Bar‐Or, Paolo A. Muraro - Nature Reviews Neurology 2021 cited by 253

  21. Five years of ocrelizumab in relapsing multiple sclerosis

    Authors: Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold, Amit Bar‐Or, Bruno Brochet, Robert T. Naismith, Anthony Traboulsee, Jerry S. Wolinsky, Shibeshih Belachew, Harold Koendgen, Victoria Levesque, Marianna Manfrini, Fabian Model, Stanislas Hubeaux, Lahar Mehta, Xavier Montalbán - Neurology 2020 cited by 158

  22. Roles of microglia in brain development, tissue maintenance and repair

    Authors: Mackenzie A. Michell‐Robinson, Hanane Touil, Luke M. Healy, David R. Owen, Bryce A. Durafourt, Amit Bar‐Or, Jack P. Antel, Craig S. Moore - Brain 2015 cited by 406

  23. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells

    Authors: Tom A. Barr, Ping Shen, Sheila Brown, Vicky Lampropoulou, Toralf Roch, S. Lawrie, Boli Fan, Richard A. O’Connor, Stephen M. Anderton, Amit Bar‐Or, Simon Fillatreau, David Gray - The Journal of Experimental Medicine 2012 cited by 643

  24. Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes

    Authors: Patrick Waters, Giulia Fadda, Mark Woodhall, Julia O’Mahony, Robert A. Brown, Denise Castro, Giulia Longoni, Sarosh R. Irani, Bo Sun, E. Ann Yeh, Ruth Ann Marrie, Douglas L. Arnold, Brenda Banwell, Amit Bar‐Or, for the Canadian Pediatric Demyelinating Disease Network - JAMA Neurology 2019 cited by 331